1
|
Klimczak A, Kempińska-Mirosławska B, Mik
M, Dziki L and Dziki A: Incidence of colorectal cancer in Poland in
1999–2008. Arch Med Sci. 7:673–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Jewell DP, Chapman RGW and Mortensen N:
Ulcerative colitis and Crohn's disease, a clinician's guide.
London: Churchill. Livingstone; pp. 791992
|
4
|
Efthymiou M, Taylor AC and Kamm MA: Cancer
surveillance strategies in ulcerative colitis. The need for
modernization. Inflmm Bowel Dis. 17:1800–1813. 2011. View Article : Google Scholar
|
5
|
Doll R and Peto R: The causes of cancer:
Quantitative estimates of avoidable risks of cancer in the United
States today. J Natl Cancer Inst. 66:1193–1308. 1981. View Article : Google Scholar
|
6
|
Willett WC: Diet, nutrition, and avoidable
cancer. Environ Health Perspect. 103 Suppl 8:165–170. 1995.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Willett WC, Stampfer MJ, Colditz GA,
Rosner BA and Speizer FE: Relation of meat, fat, and fiber intake
to the risk of colon cancer in a prospective study among women. N
Engl J Med. 323:1664–1672. 1990. View Article : Google Scholar : PubMed/NCBI
|
8
|
Chan AT and Giovannucc EL: Primary
prevention of colorectal cancer. Gastroenterology.
138:2029–2043.e10. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Farnaud S and Evans RW: Lactoferrin-a
multifunctional protein with antimicrobial properties. Mol Immunol.
40:395–405. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Fleet JC: A new role for lactoferrin: DNA
binding and transcription activation. Nutr Rev. 53:226–227. 1995.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Gibson RJ and Bowen JM: Biomarkers of
regimen-related mucosal injury. Cancer Treat Rev. 37:487–493. 2011.
View Article : Google Scholar : PubMed/NCBI
|
12
|
de Mejia EG and Dia VP: The role of
nutraceutical proteins and peptides in apoptosis, angiogenesis, and
metastasis of cancer cells. Cancer Metastasis Rev. 29:511–528.
2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Li D, Sakashita S, Morishita Y, Kano J,
Shiba A, Sato T and Noguchi M: Binding of lactoferrin to IGBP1
triggers apoptosis in a lung adenocarcinoma cell line. Anticancer
Res. 31:529–534. 2011.PubMed/NCBI
|
14
|
Tsuda H, Sekine K, Nakamura J, Ushida Y,
Kuhara T, Takasuka N, Kim DJ, Asamoto M, Baba-Toriyama H, Moore MA,
et al: Inhibition of azoxymethane initiated colon tumor and
aberrant crypt foci development by bovine lactoferrin
administration in F344 rats. Adv Exp Med Biol. 443:273–284. 1998.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Masuda C, Wanibuchi H, Sekine K, Yano Y,
Otan S, Kishimoto T, Tsuda H and Fukushima S: Chemopreventive
effects of bovine lactoferrin on
N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder
carcinogenesis. Jpn J Cancer Res. 91:582–588. 2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ushida Y, Sekine K, Kuhara T, Takasuka N,
Iigo M, Maeda M and Tsuda H: Possible chemopreventive effects of
bovine lactoferrin on esophagus and lung carcinogenesis in the rat.
Jpn J Cancer Res. 90:262–267. 1999. View Article : Google Scholar : PubMed/NCBI
|
17
|
Baskar AA, Ignacimuthu S, Paulraj GM and
Al Numair KS: Chemopreventive potential of beta-sitosterol in
experimental colon cancer model-an in vitro and in vivo study. BMC
Complement Altern Med. 10:242010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hamiza OO, Rehman MU, Tahir M, Khan R,
Khan AQ, Lateef A, Ali F and Sultana S: Amelioration of 1,2
dimethylhydrazine (DMH) induced colon oxidative stress,
inflammation and tumor promotion response by tannic acid in Wistar
rats. Asian Pac J Cancer Prev. 13:4393–4402. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Axelsson LG and Ahlstedt S: Actions of
sulphasalazine and analogues in animal models of experimental
colitis. Inflammopharmacology. 2:219–232. 1993. View Article : Google Scholar
|
20
|
Okayasu I, Hatakeyama S, Yamada M, Ohkusa
T, Inagaki Y and Nakaya R: A novel method in the induction of
reliable experimental acute and chronic ulcerative colitis in mice.
Gastroenterology. 98:694–702. 1990. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wilks S: Morbid appearances in the
intestine of Miss Bankes. London Medical Times & Gazette.
2:2641859.
|
22
|
Hou JK, Kramer JR, Richardson P, Mei M and
El-Serag HB: The incidence and prevalence of inflammatory bowel
disease among U.S, veterans: A national cohort study. Inflamm Bowel
Dis. 19:1059–1064. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Ekbom A, Helmick C, Zack M and Adami HO:
Ulcerative colitis and colorectal cancer. A population-based study.
N Engl J Med. 323:1228–1233. 1990. View Article : Google Scholar : PubMed/NCBI
|
24
|
Bernstein CN, Blanchard JF, Kliewer E and
Wajda A: Cancer risk in patients with inflmmatory bowel disease: A
population-based study. Cancer. 91:854–862. 2001. View Article : Google Scholar : PubMed/NCBI
|
25
|
Fischer R, Debbabi H, Dubarry M, Boyaka P
and Tomé D: Regulation of physiological and pathological Th1 and
Th2 responses by lactoferrin. Biochem Cell Biol. 84:303–311. 2006.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Qi G, Zeng S, Takashima T, Nozoe K,
Shobayashi M, Kakugawa K, Murakami K, Jikihara H, Zhou L and
Shimamoto F: Inhibitory Effect of Various Breads on DMH-Induced
Aberrant Crypt Foci and Colorectal Tumours in Rats. Biomed Res Int.
2015:8290962015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Blackwell TS and Christman JW: Sepsis and
cytokines: Current status. Br J Anaesth. 77:110–117. 1996.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Kawazoe A, Inubushi T, Miyauchi M,
Ishikado A, Tanaka E, Tanne K and Takata T: Orally administered
liposomal lactoferrin inhibits inflammation-related bone breakdown
without interrupting orthodontic tooth movement. J Periodontol.
84:1454–1462. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Inubushi T, Kawazoe A, Miyauchi M, Kudo Y,
Ao M, Ishikado A, Makino T and Takata T: Molecular mechanisms of
the inhibitory effects of bovine lactoferrin on
lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem.
287:23527–23536. 2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Damiens E, Mazurier J, Yazidi I, Masson M,
Duthille I, Spik G and Boilly-Marer Y: Effects of human lactoferrin
on NK cell cytotoxicity against haematopoietic and epithelial
tumour cells. Biochim Biophys Acta. 1402:277–287. 1998. View Article : Google Scholar : PubMed/NCBI
|
31
|
Shau H, Kim A and Golub SH: Modulation of
natural killer and lymphokine-activated killer cell cytotoxicity by
lactoferrin. J Leukoc Biol. 51:343–349. 1992.PubMed/NCBI
|
32
|
Casado B, Pannell LK, Iadarola P and
Baraniuk JN: Identification of human nasal mucous proteins using
proteomics. Proteomics. 5:2949–2959. 2005. View Article : Google Scholar : PubMed/NCBI
|
33
|
Legrand D and Mazurier J: A critical
review of the roles of host lactoferrin in Immunity. Biometals.
23:365–376. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Rajashekhar G, Willuweit A, Patterson CE,
Sun P, Hilbig A, Breier G, Helisch A and Clauss M: Continuous
endothelial cell activation increases angiogenesis: Evidence for
the direct role of endothelium linking angiogenesis and
inflammation. J Vasc Res. 43:193–204. 2006. View Article : Google Scholar : PubMed/NCBI
|
35
|
Parodi PW: A role for milk proteins and
their peptides in cancer prevention. Curr Pharm Des. 13:813–828.
2007. View Article : Google Scholar : PubMed/NCBI
|
36
|
Levay PF and Viljoen M: Lactoferrin: A
general review. Haematologica. 80:252–267. 1995.PubMed/NCBI
|
37
|
Iigo M, Alexander DB, Xu J, Futakuchi M,
Suzui M, Kozu T, Akasu T, Saito D, Kakizoe T, Yamauchi K, et al:
Inhibition of intestinal polyp growth by oral ingestion of bovine
lactoferrin and immune cells in the large intestine. Biometals.
27:1017–1029. 2014. View Article : Google Scholar : PubMed/NCBI
|
38
|
González-Chávez SA, Arévalo-Gallegos S and
Rascón-Cruz Q: Lactoferrin: Structure, function and applications.
Int J Antimicrob Agents. 33:301.e1–8. 2009. View Article : Google Scholar
|
39
|
Rodrigues L, Teixeira J, Schmitt F,
Paulsson M and Månsson HL: Lactoferrin and cancer disease
prevention. Crit Rev Food Sci Nutr. 49:203–217. 2009. View Article : Google Scholar : PubMed/NCBI
|